Firas Zahr and Mahesh Madhavan discuss highlights from the first day of New York Valves 2026.

Cardiovascular surgery seems to be just as safe in patients with concomitant multiple sclerosis (MS) as in those without the ...

“TAVR with the Sapien 3 platform demonstrated comparable 7-year durability to surgery, supporting its use as a treatment option in lifetime management of low-risk patients with symptomatic severe AS,” ...

While the dataset is incomplete, the death and stroke curves appear to separate at 2 years, notes Philippe Généreux.

Medically tailored meals, nurses front and center for prevention, GLP-1s and muscle mass in cardiac rehab, and more.

In a simulated cohort of patients with subclinical device-detected atrial fibrillation (AF), broad use of direct oral ...

Attendees will find 30 late-breaking clinical science and innovation presentations, the LAAC Summit, puppies, and more.

Cost-related issues have decreased as many drugs have become generic, but adherence still remains a challenge.

The proposed decision memo also paves the way for triaging by chart review and enhancing flexibility for heart team decisions ...

The combination of consistent strength training, aerobic activity, and limited sedentary time yielded the greatest benefits.

In US centers with a pulmonary embolism response team (PERT), patients with PE treated with or without advanced ...

Compared with nonusers, those on a GLP-1 receptor agonist had fewer thromboembolic events and higher survival.